低位直肠癌内括约肌切除技术和远期效果

Occurrence? [ J ]. J ComputA ssist Tomogr, 2005, 29 (1) : 42 - 50. [ 16 ]　Adachi E,Maehara S, Tsujita E, et al. Clinicopathologic risk fac2 tors for recurrence after a curative hepatic resection for hepato2 cellular carcinoma[ J ]. Surgery, 2002, 131 ( 1 supp l) : S148 - 152. [ 17 ]　O ikawa T, O jima H, Yamasaki S, et al. Multistep and multicen2 tric development of hepatocellular carcinoma: histological analy2 sis of 980 resected nodules[ J ]. J Hepatol, 2005, 42 (2) : 225 - 229. [ 18 ] 　A rii S, Yamaoka Y, Futagawa S, et al. Results of surgical and nonsurgical treatment for small2sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan[ J ]. Hepatology, 2000, 32 (6) : 1224 - 1229. [ 19 ]　Saito A. Multicentric occurrence of hepatocellular carcinoma ac2 cording to hepatitis virus status ( in Japanese) [ J ]. Kan2Tan2 Sui, 1998, 36: 185 - 188. [ 20 ]　Chen JU, Chau GY, Lui W Y, et al. Clinicopathologic Features and Factors Related to Survival of Patients with Small Hepato2 cellular Carcinoma after Hepatic Resection [ J ]. World J Surg, 2003, 27 (3) : 294 - 298. [ 21 ] 　Yasui M, Harada A, Nonam i T, et al. Potentially multicentric hepatocellular carcinoma: clinicopathologic characteristics and postoperative p rognosis[ J ]. World J Surg, 1997, 21 ( 8) : 860 - 865. [ 22 ]　Matsuda M, Fujii H, Kono H, et al. Surgical treatment of recur2 rent hepatocellular carcinoma based on the mode of recurrence: repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer[ J ]. J Hepatobiliary Pancreat Surg, 2001, 8 (4) : 353 - 359. [ 23 ] 　Poon RTP, Fan ST, Ng IOL, et al. D ifferent risk factors and p rognosis for early and late intrahepatic recurrence after resec2 tion of hepatocellular carcinoma[ J ]. Cancer, 2000, 89 (3) : 500 - 507. [ 24 ]　Kaido T, A rii S, Oe H, et al. Predictive factors affecting early re2 currence after hepatectomy for hepatocellular carcinoma in 5 - year survivors[ J ]. Hepatogastroenterology, 2005, 52 (65) : 1484 - 1487. [ 25 ]　MakuuchiM, Imamura H, Sugawara Y, et al. Progress in surgical treatment of hepatocellular carcinoma [ J ]. Oncology, 2002, 62 ( Supp l 1) : 74 - 81. [ 26 ]　Poon RT, Fan ST, Ng IO, et al. Significance of resection margin in hepatectomy for hepatocellular carcinoma: a critical reap2 p raisal[ J ]. Ann Surg, 2000, 231 (4) : 544 - 551. [ 27 ]　Suh SK. Systematic hepatectomy for small hepatocellular carci2 noma in Korea [ J ]. J Hepatobiliary Pancreat Surg, 2005, 12 (5) : 365 - 370. [ 28 ]　Ochiai T, Sonoyama T, Ichikawa D, et al. Poor p rognostic factors of hepatectomy in patients with resectable small hepatocellular carcinoma and cirrhosis [ J ]. J Cancer Res Clin Oncol, 2004, 130 (4) : 197 - 202. (2006 - 06 - 18收稿 ) 国外医学文摘 低位直肠癌内括约肌切除技术和远期效果 Ruololf S, et al. D is Colon Rectum, 2005, 48 (10) : 1858 - 1867 　　低位直肠癌内括约肌切除是将直肠切除扩大至内括约 肌间隙的一种术式 ,该手术是在腹会阴切除、直肠系膜切 除、全部或部分内括约肌切除下同时进行。该研究对此手 术的远期效果以及排便节制功能做一评估。 方法 : 1984 - 2000年共对 121例低位直肠癌施行内括 约肌切除 ,手术按照以下 : a. 肿瘤位于直肠下段和肛 管。b. 术前磁共振 (MR I)或肛内超声证实肿瘤局部转移局 限于直肠壁或内括约肌。 c. 肿瘤直径 > 1cm。 d. 术前通过 活检进行组织学分类 ( GⅠ - Ⅱ)。 e. 通过直肠指检和肛管 测压评估括约肌功能。 f. 胸部 X线和腹部超声证实无远处 转移。g. 病人在侧卧下采用乙状结肠硬镜测量肛缘至肿瘤 距离。 结果 :直肠癌 117例 ,异常绒毛腺瘤 2例 ,内癌瘤 2例。 行根治性切除 117例 ,姑息性切除 4例。肿瘤按照 Dukes 分期 ,A期 49例 (41% ) ,B期 33例 (28% ) , C期 37例 (31% ) 肿瘤距肛缘平均距离 3cm (1～5cm )。术后并发症 :根治性 切除术后 30d并发症发生率为 717% ( n = 9 ) ,病死率 018%。因肺梗死死亡 1例 ,发生吻合口漏 6例 (511% ) ,因 膀胱尿道漏再次手术 1例 ,肠梗阻 1例以及腹内出血和小 肠漏 1例需再次手术 ,保护性结肠造口关闭后发生漏 1例 , 结肠肛管吻合口狭窄 11例 ( 914% )。平均随访 94个月 (24～185个月 ) ,局部复发 6例 ( 513% ) ,按照肛管节制功 能评分 ,节制功能正常 101例 (8613% ) ,仅固体便节制功能 正常 16例 (1317% ) ,排便失禁 1例 (018% )。每天平均排 便次数为 2124次 (1～9次 )。 结论 :对于保护括约肌的直肠手术 ,采用内括约肌切除 是可行的。研究显示 ,该手术远期效果和功能满意 ,重要的 必备条件是术前通过 MR I对肿瘤扩散进行仔细评估 ,排除 外括约肌浸润。 (龚 　苏 摘译 　喻德洪 审校 ) ·256· 中国实用外科杂志 2006年 9月 第 26卷 第 9期